Evidence map›Paper›PMID 38124289›Full record

ArticleThe journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians2024

Outcomes in low-risk patients before and after an institutional policy offering 39-week elective induction of labor.

Gabriella D Cozzi-Glaser, Christina T Blanchard, Jenna N Stanford, Ayamo G Oben, Victoria C Jauk, Jeff M Szychowski, Akila Subramaniam, Ashley N Battarbee, Brian M Casey, Alan T Tita and 1 more

Open access · diamondAbstract read
In one paragraph

Article in The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Gabriella D Cozzi-GlaserCenter for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, AL, USA.
Christina T BlanchardCenter for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, AL, USA.
Jenna N StanfordCenter for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, AL, USA.
Ayamo G ObenCenter for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, AL, USA.
Victoria C JaukCenter for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, AL, USA.
Jeff M SzychowskiCenter for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, AL, USA.
Akila SubramaniamCenter for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, AL, USA.
Ashley N BattarbeeCenter for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, AL, USA.
Brian M CaseyCenter for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, AL, USA.
Alan T TitaCenter for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, AL, USA.
Rachel G SinkeyCenter for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, AL, USA.
University of Alabama at Birmingham · US

Funding

The ACHIEVE Trial: Achieving longer gestation in preeclampsia via antihypertensive therapy.K23HL159331 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Rachel G Sinkey · 2022 to 2026
$884k
Close the GAP: Glycemic control after Antenatal corticosteroids in women with Pregestational diabetesK23HD103875 · NICHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BATTARBEE, ASHLEY NICOLE · 2021 to 2025
$826k
NHLBI NIH HHS K23 HL159331NICHD NIH HHS K23 HD103875
6 · The paper itself

Abstract

objectiveElective induction of labor versus expectant management at 39 weeks gestation in low-risk nulliparous patients was shown in the ARRIVE randomized trial of over 6000 patients to decrease risks of cesarean delivery without significant change in the composite perinatal outcome. We aimed to pragmatically analyze the effect of offering elective induction of labor (eIOL) to all low-risk patients.

methodsRetrospective cohort study of low-risk nulliparous and multiparous patients delivering live, non-anomalous singletons at a single center at greater than or equal to 39 0/7 weeks gestational age. Those with prior or planned cesarean delivery, ruptured membranes, medical comorbidities, or contraindications to vaginal delivery were excluded. Patients were categorized as before (pre-eIOL; 1/2012-3/2014) or after (post-eIOL; 3/2019-12/2021) an institution-wide policy offering eIOL at 39 0/7 weeks. Births occurring April 2014 to December 2018 were allocated to a separate cohort (during-eIOL) given increased exposure to eIOL as our center recruited participants for the ARRIVE trial. The primary outcome was cesarean birth. Secondary outcomes included select maternal (e.g. chorioamnionitis, operative delivery, postpartum hemorrhage) and neonatal morbidities (e.g. birthweight, small- and large-for gestational age, hypoglycemia). Characteristics and outcomes were compared between the pre and during-eIOL, and pre and post-eIOL groups; adjusted OR (95% CI) were calculated using multivariable regression. Subgroup analysis by parity was planned.

resultsOf 10,758 patients analyzed, 2521 (23.4%) were pre-eIOL, 5410 (50.3%) during-eIOL, and 2827 (26.3%) post-eIOL. Groups differed with respect to labor type, age, race/ethnicity, marital and payor status, and gestational age at care entry. Post-eIOL was associated with lower odds of cesarean compared to pre-eIOL (aOR 0.83 [95% CI 0.72-0.96]), which was even lower among those specifically undergoing labor induction (aOR 0.58 [0.48-0.70]. During-eIOL was also associated with lower odds of cesarean compared to pre-eIOL (aOR 0.79 [0.69-0.90]). Both during and post-eIOL groups were associated with higher odds of chorioamnionitis, operative delivery, and hemorrhage compared to pre-eIOL. However, only among post-eIOL were there fewer neonates weighing ≥4000 g, large-for-gestational age infants, and neonatal hypoglycemia compared to pre-IOL.

conclusionAn institutional policy offering eIOL at 39 0/7 to low-risk patients was associated with a lower cesarean birth rate, lower birthweights and lower neonatal hypoglycemia, and an increased risk of chorioamnionitis and hemorrhage.

Indexed as

ChorioamnionitisHypoglycemiaInfant, Newborn, DiseasesPostpartum HemorrhageFemaleGestational AgeHumansInfant, NewbornLabor, InducedOrganizational PolicyPregnancyRandomized Controlled Trials as TopicRetrospective StudiesCesarean deliverychorioamnionitishemorrhageneonatal hypoglycemia

Identifiers

PMID38124289
PMCPMC10958525
OpenAlexW4390057072

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.